Rui Peng

12.5k total citations · 9 hit papers
118 papers, 10.3k citations indexed

About

Rui Peng is a scholar working on Molecular Biology, Biomedical Engineering and Immunology. According to data from OpenAlex, Rui Peng has authored 118 papers receiving a total of 10.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 39 papers in Biomedical Engineering and 23 papers in Immunology. Recurrent topics in Rui Peng's work include Nanoplatforms for cancer theranostics (23 papers), Immunotherapy and Immune Responses (16 papers) and RNA Interference and Gene Delivery (14 papers). Rui Peng is often cited by papers focused on Nanoplatforms for cancer theranostics (23 papers), Immunotherapy and Immune Responses (16 papers) and RNA Interference and Gene Delivery (14 papers). Rui Peng collaborates with scholars based in China, United States and Hong Kong. Rui Peng's co-authors include Zhuang Liu, Ligeng Xu, Jun Xu, Chao Wang, Qian Chen, Chao Liang, Xiaoqi Sun, Yu Chao, Liangzhu Feng and Guangbao Yang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Rui Peng

112 papers receiving 10.3k citations

Hit Papers

Photothermal therapy with immune-adjuvant nanoparticles t... 2013 2026 2017 2021 2016 2017 2017 2018 2014 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy
    2016 1.4k citations Qian Chen, Ligeng Xu et al. profile →
  2. Hollow MnO2 as a tumor-microenvironment-responsive biodegradable nano-platform for combination therapy favoring antitumor immune responses
    2017 1.3k citations Ligeng Xu, Yu Chao et al. profile →
  3. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer
    2017 616 citations Jun Xu, Ligeng Xu et al. profile →
  4. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination
    2018 607 citations Jun Xu, Ligeng Xu et al. profile →
  5. Immunological Responses Triggered by Photothermal Therapy with Carbon Nanotubes in Combination with Anti‐CTLA‐4 Therapy to Inhibit Cancer Metastasis
    2014 486 citations Chao Wang, Ligeng Xu et al. profile →
  6. A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy
    2020 459 citations Jun Xu, Jia Lv et al. Nature Nanotechnology profile →
  7. Graphene Oxide–Silver Nanocomposite As a Highly Effective Antibacterial Agent with Species-Specific Mechanisms
    2013 417 citations Qian Chen, Ligeng Xu et al. profile →
  8. PKCα/ZFP64/CSF1 axis resets the tumor microenvironment and fuels anti-PD1 resistance in hepatocellular carcinoma
    2022 114 citations Rui Peng et al. profile →
  9. Oncolytic mineralized bacteria as potent locally administered immunotherapeutics
    2024 59 citations Chenya Wang, Liping Zhong et al. Nature Biomedical Engineering profile →

Peers

Rui Peng
Ligeng Xu China
Xianzhu Yang China
Rui Tian China
Wei Liu China
Guizhi Zhu United States
Jinqiang Wang China
Xiaoqi Sun China
Xintao Shuai China
Lintao Cai China
Ligeng Xu China
Rui Peng
Citations per year, relative to Rui Peng Rui Peng (= 1×) peers Ligeng Xu

Countries citing papers authored by Rui Peng

Since Specialization
Citations

This map shows the geographic impact of Rui Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rui Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rui Peng more than expected).

Fields of papers citing papers by Rui Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rui Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rui Peng. The network helps show where Rui Peng may publish in the future.

Co-authorship network of co-authors of Rui Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Rui Peng. A scholar is included among the top collaborators of Rui Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rui Peng. Rui Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tang, Min, et al.. (2025). Unexplored role of nanoconfinement in regulating contaminant oxidation pathways for water decontamination: Confined energy driving low-carbon route. Chemical Engineering Journal. 507. 160733–160733. 3 indexed citations
2.
Wang, Wanrong, Xue–Qian Li, Rui Peng, et al.. (2025). Reversing hypoxia-induced immune evasion in tumors to enhance cancer immunotherapy. Journal of Controlled Release. 382. 113745–113745. 1 indexed citations
3.
4.
Zhang, Shiyuan, et al.. (2025). Mineralized Bacteria as a Potent Vaccine Against Staphylococcus aureus Infections. Small. 21(20). e2412279–e2412279.
5.
Peng, Rui, Chen Chen, Jun Cao, et al.. (2025). FBXO32 ubiquitination of SUFU promotes progression and lenvatinib resistance in hepatocellular carcinoma via hedgehog signaling. Medical Oncology. 42(4). 98–98. 2 indexed citations
6.
Peng, Rui, et al.. (2024). Dynamic Control Design of Tidal Lanes of Intelligent Highway Toll Station: A Case Study of Xiongan New Area, China. KSCE Journal of Civil Engineering. 28(12). 5841–5850. 1 indexed citations
7.
Zha, He, Tianhui Wu, Handeng Liu, et al.. (2024). Cytosolic Hmgb1 accumulation in mesangial cells aggravates diabetic kidney disease progression via NFκB signaling pathway. Cellular and Molecular Life Sciences. 81(1). 408–408. 9 indexed citations
8.
Xu, Yidi, Jie Yang, Rui Peng, et al.. (2024). Apoptotic body-inspired nanotherapeutics efficiently attenuate osteoarthritis by targeting BRD4-regulated synovial macrophage polarization. Biomaterials. 306. 122483–122483. 16 indexed citations
9.
Wang, Chenya, Liping Zhong, Jiachen Xu, et al.. (2024). Oncolytic mineralized bacteria as potent locally administered immunotherapeutics. Nature Biomedical Engineering. 8(5). 561–578. 59 indexed citations breakdown →
10.
Tang, Xun, Jun Wu, Yan Chen, et al.. (2024). Evaluation of 5′-tRF-His-GTG As a Molecular Biomarker in Breast Cancer Diagnoses and Prognosis. Cancer Biotherapy and Radiopharmaceuticals. 39(6). 441–450. 4 indexed citations
11.
Peng, Rui, et al.. (2023). IL-37 inhibits glycolysis of lung adenocarcinoma by inhibiting the expression of PFKFB3. Cellular and Molecular Biology. 69(15). 265–269. 1 indexed citations
12.
Zhou, Jie, Rui Peng, Hao Tang, et al.. (2023). RNF173 suppresses RAF/MEK/ERK signaling to regulate invasion and metastasis via GRB2 ubiquitination in Hepatocellular Carcinoma. Cell Communication and Signaling. 21(1). 224–224. 17 indexed citations
13.
Jiang, Hui, et al.. (2023). Mechanism of PGC-1α-mediated mitochondrial biogenesis in cerebral ischemia–reperfusion injury. Frontiers in Molecular Neuroscience. 16. 1224964–1224964. 25 indexed citations
14.
Zhang, Xiao‐Yong, Yanyan Liu, Shuo Tao, et al.. (2023). Downregulation of mGluR1-mediated signaling underlying autistic-like core symptoms in Shank1 P1812L-knock-in mice. Translational Psychiatry. 13(1). 329–329. 2 indexed citations
15.
Chen, Zhan, Jie Jiang, Yong Zhang, et al.. (2023). Identification and validation of fatty acid metabolism-related lncRNA signatures as a novel prognostic model for clear cell renal cell carcinoma. Scientific Reports. 13(1). 7043–7043. 3 indexed citations
16.
Chen, Zhan, Jie Jiang, Yong Zhang, et al.. (2022). A new CCCH-type zinc finger-related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma patients. Frontiers in Genetics. 13. 1034567–1034567. 1 indexed citations
17.
Jiang, Yuchao, Shuxia Chen, Ke Su, et al.. (2021). Rare variants in TULP3 abolish the suppressive effect on sonic hedgehog signaling and contribute to human neural tube defects. Genes & Diseases. 9(5). 1174–1177. 5 indexed citations
18.
Xu, Jun, Jia Lv, Qi Zhuang, et al.. (2020). A general strategy towards personalized nanovaccines based on fluoropolymers for post-surgical cancer immunotherapy. Nature Nanotechnology. 15(12). 1043–1052. 459 indexed citations breakdown →
19.
Wang, Yao, et al.. (2017). The prognostic value of preoperative serum HDL cholesterol in patients with resectable acral melanoma. 10(3). 5134–5142. 1 indexed citations
20.
Jiang, Li, et al.. (2008). Expression of chemokine receptor CXCR4 in nasopharyngeal carcinoma. Zhonghua zhongliu fangzhi zazhi. 15(8). 594–596. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ligeng Xu Breakdown of academic impact, for papers by Xianzhu Yang Breakdown of academic impact, for papers by Rui Tian Breakdown of academic impact, for papers by Wei Liu Breakdown of academic impact, for papers by Guizhi Zhu Breakdown of academic impact, for papers by Jinqiang Wang Breakdown of academic impact, for papers by Xiaoqi Sun Breakdown of academic impact, for papers by Xintao Shuai Breakdown of academic impact, for papers by Lintao Cai
Rankless by CCL
2026